Features
Dissecting movement disorders through the eyes of a fly
12 October 2020In the search for new therapeutics and diagnostic tools, Sherry Aw is unraveling the biology behind movement disorders using the humble fruit fly.
Staying ahead of the (infection) curve
30 September 2020Serology testing may be fast and easy to perform, but there are still some limitations that need to be overcome, suggests Laurent Renia.
Placing a ‘hit’ on the crown
11 September 2020Could there be a drug that can both treat and protect against COVID-19? The answer may be found in antibody drugs, a promising therapeutic modality against the coronavirus.
Identifying antibodies that work
9 September 2020A new test manufactured by A*STAR’s Diagnostics Development Hub in partnership with Duke-NUS Medical School could reveal if an individual is likely immune to COVID-19.
Bioinformatics: At the forefront, behind the scenes
4 September 2020Sebastian Maurer-Stroh shares how bioinformatics has enabled Singapore to respond quickly to COVID-19 and will continue to play an important role in ongoing surveillance.
The mutation making COVID-19 milder
24 August 2020Scientists at A*STAR have found that a mutation in SARS-CoV-2 called ∆382 leads to milder clinical outcomes, with implications for COVID-19 treatments and vaccines.
Finding the ideal disinfection agent
7 August 2020Regular disinfection can help to limit the spread of viral infections such as COVID-19, but only if carried out appropriately, write Xian Jun Loh and colleagues.
Taming abnormal blood vessel growth
29 July 2020Uttam Surana shares how SiNOPSEE Therapeutics, the biopharmaceutical startup he co-founded, is developing drugs to block angiogenesis in cancer and degenerative eye conditions.
The fast track to Fortitude
27 July 2020In a display of scientific willpower, A*STAR researchers developed and deployed the COVID-19 diagnostic Fortitude Kit within weeks of the virus reaching Singapore’s shores.
The Curiox case for better cell analysis
25 June 2020Curiox Biosystems, an A*STAR spin-off company, specializes in automated and quantitative cell analysis. Its CEO, Namyong Kim, shares the story of the company’s success.
Shining a light on quantum materials
12 June 2020By manipulating light to reveal unusual properties of quantum materials, Justin Song is ushering in a new age of quantum devices.
Leading the way in microRNA technology
21 May 2020After a decade of research and innovation, homegrown biotech company MiRXES can now call themselves a global leader in developing microRNA-based technology to solve real-world issues.
What we know about COVID-19 and how it can be treated
14 May 2020Lisa F. P. Ng, a leading infectious disease expert on infection and immunity, shares how her team’s prior experience has helped them quickly understand the nature of SARS-CoV-2, the virus that causes COVID-19.
